Your browser doesn't support javascript.
loading
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.
Jearanaiwitayakul, Tuksin; Seesen, Mathurin; Chawengkirttikul, Runglawan; Limthongkul, Jitra; Apichirapokey, Suttikarn; Sapsutthipas, Sompong; Phumiamorn, Supaporn; Sunintaboon, Panya; Ubol, Sukathida.
Afiliación
  • Jearanaiwitayakul T; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Seesen M; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Chawengkirttikul R; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Limthongkul J; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Apichirapokey S; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Sapsutthipas S; Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.
  • Phumiamorn S; Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.
  • Sunintaboon P; Department of Chemistry, Faculty of Science, Mahidol University, Salaya, Nakornpatom 73170, Thailand.
  • Ubol S; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Vaccines (Basel) ; 9(7)2021 Jul 09.
Article en En | MEDLINE | ID: mdl-34358183

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Tailandia

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Tailandia